AstraZeneca follows Merck with Phase 3 win in bladder cancer
A combination of AstraZeneca's Imfinzi with Pfizer and Astellas’ Padcev kept more bladder cancer patients alive than standard of care, the company said Thursday. AstraZeneca said it would seek approval for the combination, but it ...
May 14, 2026 10:31 AM EDT R&D AstraZeneca follows Merck with Phase 3 win in bladder cancer Elizabeth Cairns Senior biopharma journalist A combination of AstraZeneca’s Imfinzi with Pfizer and Astellas’ Padcev kept more bladder cancer patients alive than standard of care, the company said Thursday. AstraZeneca … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that